← Back to Search

Behavioral Intervention

Telementoring for Cancer Survivorship Care (KANSURVIVE Trial)

N/A
Waitlist Available
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must be capable and willing to complete pre- and post- data collection
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 month
Awards & highlights

KANSURVIVE Trial Summary

This trial will help identify how to better provide cancer survivorship care in rural areas.

Who is the study for?
The KanSurvive trial is for rural primary care practices in Kansas that are willing to improve cancer survivorship care. They must participate in four telementoring sessions and complete data collection before and after the intervention.Check my eligibility
What is being tested?
This study tests a new model called KanSurvive-ECHO, aimed at enhancing cancer care after treatment. It involves evaluating work flows, training through ECHO sessions, and assessing the model's effectiveness in improving survivorship care.See study design
What are the potential side effects?
Since this trial focuses on educational interventions rather than medical treatments, traditional side effects are not applicable. However, there may be challenges related to changes in practice workflow or adoption of new procedures.

KANSURVIVE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am willing and able to provide information before and after the trial.

KANSURVIVE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent change in evidence based cancer screening
Other outcome measures
Participation rates in the Telementoring and Practice Facilitation Sessions

KANSURVIVE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: cluster-randomized controlled trial, interventionExperimental Treatment1 Intervention
Intervention arm
Group II: cluster-randomized controlled trial, with delayed start control armActive Control1 Intervention
Control arm/Delayed Onset

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
458 Previous Clinical Trials
168,688 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,621 Previous Clinical Trials
40,927,022 Total Patients Enrolled

Media Library

KanSurvive-ECHO (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04763824 — N/A
Colorectal Cancer Research Study Groups: cluster-randomized controlled trial, with delayed start control arm, cluster-randomized controlled trial, intervention
Colorectal Cancer Clinical Trial 2023: KanSurvive-ECHO Highlights & Side Effects. Trial Name: NCT04763824 — N/A
KanSurvive-ECHO (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04763824 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor actively seeking participants?

"Correct. According to the clinicaltrials.gov portal, this medical trial is currently enrolling patients who first posted on November 18th 2020. The most recent update was published February 18th 2021 and 20 participants need to be recruited at a single site."

Answered by AI

How many participants are in this clinical trial?

"Affirmative. Clinicaltrials.gov data highlights that, beginning on November 18th 2020, this clinical trial is presently accepting enrolment applications. 20 patients are sought from a single participating site."

Answered by AI
~28 spots leftby Jul 2024